Amy DeZern, MD, MHS
The AAMDSIF Leadership in Science Award was presented to Amy DeZern, MD, MHS, at our 8th International
IMPORTANT: UPDATED Guidance for Patients on COVID-19 including Vaccine Information»
Recipients are selected for their contributions to the fields of bone marrow failure disease treatment and/or research. Nominees are considered for their impact on patients and families affected by aplastic anemia, MDS and PNH, and/or their contributions through research to increasing knowledge and understanding about these diseases. Additional consideration is given to those who have demonstrated a commitment to AA&MDSIF.
The AAMDSIF Leadership in Science Award was presented to Amy DeZern, MD, MHS, at our 8th International
Dr. Becker is a pioneering leader in translational research and optimizing therapy of hematological malignancies. She is a highly respected clinician with expertise in
Dr. Santini leads the MDS program in the Hematology Unit at the Azienda Ospedaliero Universitaria Careggi Medical School, University of Florence. She was recognized for her scientific interests and publications focused on maturation induction and therapeutic targeting of epigenetics modifications, myeloid leukemias, and
Dr. Young's research interests are in human hematopoiesis,
Dr. Steensma is Professor of Medicine at Harvard Medical School and Attending Physician at Dana-Farber Cancer Institute and Brigham and Women’s Hospital in Boston, Massachusetts. His primary area of clinical activity and research focus is
Dr. Sekeres is associate professor of medicine and Director of the Leukemia Program, Department of Hematologic Oncology and Blood Disorders with the Cleveland Clinic Taussig Cancer Institute, Ohio. He earned a medical degree and a master’s in clinical
Dr. Stone cares for patients with acute and chronic leukemias, myelodysplasia and myeloproliferative disorders. Dr. Stone conducts clinical and translational research with the goal of deriving better outcomes for patients with these disorders. His laboratory research focuses on the mechanism of leukemic cell differentiation, with the ultimate goal of producing new cancer therapies.
Dr. Maciejewski is recognized for his leadership in finding better treatments and a cure for